S&P may downgrade the EU and the largest eurozone banks. (Reuters) France and Germany continue to press new eurozone treaty measures that would help trigger new financing for the region. (Reuters) Japan says…
Dividends are still rising and equity and income investors should expect more of the same for 2012. The Walt Disney Company (NYSE: DIS) joined in on the dividend hike brigade with another dividend…
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) has had its share of trouble in 2011, but perhaps the expiring patent on that statin Lipitor by Pfizer Inc. (NYSE: PFE) may offer some reprieve. …
It has been a long time coming, and now many patients will be able to switch to a generic. Pfizer Inc. (NYSE: PFE) has now officially lost its patent over its cholesterol-lowering…
The EU continues to work on its bailout fund and may ask the IMF for help. (Reuters) American Airlines parent AMR (NYSE: AMR) files for Chapter 11. (Reuters) S&P cuts its ratings on…
Pfizer Inc. (NYSE: PFE) has a big day ahead of it. While it has been known for years, it is a massive date: Lipitor goes off-patent and will have generic versions of…
It now costs about $1 billion to get a new drug to market, or, if a company is unlucky, $1 billion to fail to get the drug to market. Like the movie…
The supercommittee appears unlikely to settle on a deficit agreement. (Reuters) A senior Chinese official says he expects the global recession to last for some time. (Reuters) Spain’s center-right People’s Party gains…
Some companies just want to keep bringing on new share buybacks whether they work or not. Some are to stop dilution from acquisitions or employee stock options, while others are to reduce…
The economic choppiness is coming to a head with the age of dividend hikes. The pressure is going to remain for companies to continue returning capital to shareholders while also looking for…
George Papandreou convinces the Greek cabinet of the virtues of a national referendum on budget cuts, but he now faces the leaders of France and Germany. (Reuters) The FBI may investigate the…
The markets are beyond jittery. From a massively overbought market discounting a recession entirely back to a market dominated by the woes of Europe. The Europeans cannot get their bailouts straight because each…
Earnings season is still running strong and the economic readings keep coming out as well. As we come to the end of October, there is going to be plenty of news coming…
Short sellers moved out of stocks that have fallen recently. Perhaps they believe there will be a large rally in the market. There is little else to make the shares of companies…
Novartis (NYSE: NVS) said it would cut 2,000 workers and outsource some functions to companies that will do the work for less than it can. Novartis will take a restructuring charge of…
